Drug Shortage Report for PROLENSA
| Report ID | 169125 |
| Drug Identification Number | 02439123 |
| Brand name | PROLENSA |
| Common or Proper name | PROLENSA |
| Company Name | BAUSCH & LOMB INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BROMFENAC |
| Strength(s) | 0.07% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 3ml |
| ATC code | S01BC |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2022-09-05 |
| Estimated end date | 2022-11-14 |
| Actual end date | 2022-10-27 |
| Shortage status | Resolved |
| Updated date | 2022-10-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-10-28 | French | Compare |
| v6 | 2022-10-28 | English | Compare |
| v5 | 2022-10-12 | French | Compare |
| v4 | 2022-10-12 | English | Compare |
| v3 | 2022-09-12 | French | Compare |
| v2 | 2022-09-12 | English | Compare |
| v1 | 2022-09-12 | English | Compare |
Showing 1 to 7 of 7